Clinical Scorecard: Variability in HbA1c Levels Across Visits and Its Impact on Renal Function Deterioration in Older Adults with Type 2 Diabetes

At a Glance

Key Highlights

• Higher visit-to-visit HbA1c variability is linked to increased risk of renal function decline.
• Each 5% increase in HbA1c coefficient of variation (HbA1c-CV) correlates with a 19% higher risk of renal decline.
• The highest tertile of HbA1c-CV shows a 58% increased risk of renal decline compared to the lowest tertile.
• The study included 630 participants with a median follow-up of 4.6 years.
• Renal decline was defined as confirmed ≥20% eGFR decline or eGFR <15 mL/min/1.73 m2.

Guideline-Based Recommendations

Diagnosis

• Assess HbA1c variability in conjunction with mean HbA1c for a comprehensive evaluation of glycemic control.

Management

• Integrate prognosis, functional reserve, and treatment burden in management decisions for older adults with diabetes.

Monitoring & Follow-up

• Monitor visit-to-visit HbA1c variability as a potential prognostic signal for renal function.

Risks

• Consider the increased risk of renal decline associated with higher HbA1c variability.

Patient & Prescribing Data

Older Chinese adults with type 2 diabetes

Glycemic targets should be individualized, considering the risks of renal decline.

Clinical Best Practices

• Utilize a fixed exposure window for assessing HbA1c variability to minimize bias.
• Regularly evaluate renal function alongside glycemic control metrics.

Related Resources & Content

• Study on HbA1c variability and renal outcomes